{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:31:29Z","timestamp":1773271889391,"version":"3.50.1"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare progressive genetic disease effecting one in a million individuals. During their life, patients with FOP progressively develop bone in the soft tissues resulting in increasing immobility and early death. A mutation in the <jats:italic>ACVR1<\/jats:italic> gene was identified as the causative mutation of FOP in 2006. After this, the pathophysiology of FOP has been further elucidated through the efforts of research groups worldwide. In 2015, a workshop was held to gather these groups and discuss the new challenges in FOP research. Here we present an overview and update on these topics.<\/jats:p>","DOI":"10.3389\/fendo.2021.732728","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:01:21Z","timestamp":1636545681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop"],"prefix":"10.3389","volume":"12","author":[{"given":"Ruben D.","family":"de Ruiter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Smilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Pals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bravenboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Knaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ton","family":"Schoenmaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esm\u00e9e","family":"Botman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"S\u00e1nchez-Duffhues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Oosterwyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Bocciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Laura","family":"De Cunto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Longo Ribeiro Delai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teun J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Hilderbrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Koolwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Morhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Netelenbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rustemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Stockklausner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Triffit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ravazzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Micha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M. W.","family":"Eekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.00705","article-title":"Early Mortality and Cardiorespiratory Failure in Patients With Fibrodysplasia Ossificans Progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J Bone Joint Surg Am Vol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1783","article-title":"A Recurrent Mutation in the BMP Type I Receptor ACVR1 Causes Inherited and Sporadic Fibrodysplasia Ossificans Progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in Fibrodysplasia Ossificans Progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.094557","article-title":"Molecular Consequences of the ACVR1(R206H) Mutation of Fibrodysplasia Ossificans Progressiva","volume":"285","author":"Song","year":"2010","journal-title":"J Biol Chem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190377","article-title":"The Role of Activin A in Fibrodysplasia Ossificans Progressiva: A Prominent Mediator","volume":"39","author":"Lin","year":"2019","journal-title":"Biosci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1749-6632.2011.06195.x","article-title":"Fibrodysplasia Ossificans Progressiva: A Blueprint for Metamorphosis","volume":"1237","author":"Kaplan","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1389202920666190116094736","article-title":"An Overview About the Biology of Skeletal Muscle Satellite Cells","volume":"20","author":"Forcina","year":"2019","journal-title":"Curr Genomics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.2001.680412.x","article-title":"Muscle Satellite Cells are Multipotential Stem Cells That Exhibit Myogenic, Osteogenic, and Adipogenic Differentiation","volume":"68","author":"Asakura","year":"2001","journal-title":"Differentiation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.H.01177","article-title":"Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis","volume":"91","author":"Lounev","year":"2009","journal-title":"J Bone Joint Surg Am Vol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.01.029","article-title":"Stem Cells and Heterotopic Ossification: Lessons From Animal Models","volume":"109","author":"Lees-Shepard","year":"2018","journal-title":"Bone"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2252","article-title":"Conversion of Vascular Endothelial Cells Into Multipotent Stem-Like Cells","volume":"16","author":"Medici","year":"2010","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1562","article-title":"Multipotent Progenitors Resident in the Skeletal Muscle Interstitium Exhibit Robust BMP-Dependent Osteogenic Activity and Mediate Heterotopic Ossification","volume":"27","author":"Wosczyna","year":"2012","journal-title":"J Bone Mineral Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-Dependent Signaling in Fibro\/Adipogenic Progenitors Causes Fibrodysplasia Ossificans Progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00003086-199801000-00005","article-title":"Acute Lymphocytic Infiltration in an Extremely Early Lesion of Fibrodysplasia Ossificans Progressiva","author":"Gannon","year":"1998","journal-title":"Clin Orthopaedics Rel Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.26464","article-title":"Mast Cell Involvement in Fibrodysplasia Ossificans Progressiva","volume":"32","author":"Gannon","year":"2001","journal-title":"Hum Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1(R206H) Mouse Model of Fibrodysplasia Ossificans Progressiva","volume":"33","author":"Convente","year":"2018","journal-title":"J Bone Mineral Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1315153111","article-title":"Osteal Macrophages Support Physiologic Skeletal Remodeling and Anabolic Actions of Parathyroid Hormone in Bone","volume":"111","author":"Cho","year":"2014","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01640","article-title":"Severe Heterotopic Ossification in the Skeletal Muscle and Endothelial Cells Recruitment to Chondrogenesis Are Enhanced by Monocyte\/Macrophage Depletion","volume":"10","author":"Tirone","year":"2019","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.12.024","article-title":"ECSIT Links TLR and BMP Signaling in FOP Connective Tissue Progenitor Cells","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122958","article-title":"NF-Kappab\/MAPK Activation Underlies ACVR1-Mediated Inflammation in Human Heterotopic Ossification","volume":"3","author":"Barruet","year":"2018","journal-title":"JCI Insight"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-019-00541-x","article-title":"Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification","volume":"17","author":"Matsuo","year":"2019","journal-title":"Curr Osteoporosis Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21594","article-title":"Peripheral Blood Mononuclear Cell Immunophenotyping in Fibrodysplasia Ossificans Progressiva Patients: Evidence for Monocyte DNAM1 Up-Regulation","volume":"94","author":"Del Zotto","year":"2018","journal-title":"Cytomet Part B Clin Cytomet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/stem.150","article-title":"Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation","volume":"27","author":"Suda","year":"2009","journal-title":"Stem Cells (Dayton Ohio)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2848","article-title":"Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J Bone Mineral Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1(R206H) FOP Mutation Alters Mechanosensing and Tissue Stiffness During Heterotopic Ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol Biol Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.febslet.2012.04.030","article-title":"BMP Signaling in Vascular Diseases","volume":"586","author":"Cai","year":"2012","journal-title":"FEBS Lett"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2014.07.006","article-title":"Role of Angiogenesis in Bone Repair","volume":"561","author":"Saran","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700193RR","article-title":"Role of Bone Morphogenetic Proteins in Sprouting Angiogenesis: Differential BMP Receptor-Dependent Signaling Pathways Balance Stalk vs. Tip Cell Competence","volume":"31","author":"Benn","year":"2017","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-020-10103-9","article-title":"ActivinA Induced SMAD1\/5 Signaling in an iPSC Derived EC Model of Fibrodysplasia Ossificans Progressiva (FOP) Can Be Rescued by the Drug Candidate Saracatinib","volume":"17","author":"Hildebrandt","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1995.tb01152.x","article-title":"Ultrastructural Finding of Vascular Degeneration in Fibrodysplasia Ossificans Progressiva (FOP)","volume":"24","author":"el-Labban","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.179960","article-title":"VE-Cadherin Facilitates BMP-Induced Endothelial Cell Permeability and Signaling","volume":"129","author":"Benn","year":"2016","journal-title":"J Cell Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e10230","DOI":"10.1002\/jbm4.10230","article-title":"Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells","volume":"3","author":"S\u00e1nchez-Duffhues","year":"2019","journal-title":"JBMR Plus"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.01.004","article-title":"Inhibition of Tgf\u03b2 Signaling Decreases Osteogenic Differentiation of Fibrodysplasia Ossificans Progressiva Fibroblasts in a Novel In Vitro Model of the Disease","volume":"84","author":"Micha","year":"2016","journal-title":"Bone"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.07.007","article-title":"Periodontal Ligament Fibroblasts as a Cell Model to Study Osteogenesis and Osteoclastogenesis in Fibrodysplasia Ossificans Progressiva","volume":"109","author":"de Vries","year":"2018","journal-title":"Bone"},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13287-016-0372-6","article-title":"The ACVR1 R206H Mutation Found in Fibrodysplasia Ossificans Progressiva Increases Human Induced Pluripotent Stem Cell-Derived Endothelial Cell Formation and Collagen Production Through BMP-Mediated SMAD1\/5\/8 Signaling","volume":"7","author":"Barruet","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2015.10.020","article-title":"Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva","volume":"5","author":"Cai","year":"2015","journal-title":"Stem Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.071030","article-title":"Dysregulated BMP Signaling and Enhanced Osteogenic Differentiation of Connective Tissue Progenitor Cells From Patients With Fibrodysplasia Ossificans Progressiva (FOP)","volume":"23","author":"Billings","year":"2008","journal-title":"J Bone Mineral Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of Normal BMP Signaling Levels and Osteogenic Differentiation in FOP Mesenchymal Progenitor Cells by Mutant Allele-Specific Targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bone.2019.07.031","article-title":"Activation of G(q) Signaling by Pasteurella Multocida Toxin Inhibits the Osteoblastogenic-Like Actions of Activin A in C2C12 Myoblasts, a Cell Model of Fibrodysplasia Ossificans Progressiva","volume":"127","author":"Ebner","year":"2019","journal-title":"Bone"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.22779","article-title":"Hyperactive BMP Signaling Induced by ALK2(R206H) Requires Type II Receptor Function in a Drosophila Model for Classic Fibrodysplasia Ossificans Progressiva","volume":"241","author":"Le","year":"2012","journal-title":"Dev Dynamics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37412","article-title":"The Fibrodysplasia Ossificans Progressiva R206H ACVR1 Mutation Activates BMP-Independent Chondrogenesis and Zebrafish Embryo Ventralization","volume":"119","author":"Shen","year":"2009","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801681200","article-title":"Constitutively Activated ALK2 and Increased SMAD1\/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva","volume":"284","author":"Fukuda","year":"2009","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H Mutation Linked to Fibrodysplasia Ossificans Progressiva Confers Constitutive Activity to the BMP Type I Receptor and Sensitizes Mesenchymal Cells to BMP-Induced Osteoblast Differentiation and Bone Formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"J Bone Mineral Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu255","article-title":"ACVR1 P.Q207E Causes Classic Fibrodysplasia Ossificans Progressiva and is Functionally Distinct From the Engineered Constitutively Active ACVR1 P.Q207D Variant","volume":"23","author":"Haupt","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/dvg.20201","article-title":"Generation of a Mouse With Conditionally Activated Signaling Through the BMP Receptor, ALK2","volume":"44","author":"Fukuda","year":"2006","journal-title":"Genesis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1888","article-title":"BMP Type I Receptor Inhibition Reduces Heterotopic [Corrected] Ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H Knock-in Mouse has Fibrodysplasia Ossificans Progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J Bone Mineral Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3235","article-title":"The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent","volume":"32","author":"Upadhyay","year":"2017","journal-title":"J Bone Mineral Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H Receptor Mutation Causes Fibrodysplasia Ossificans Progressiva by Imparting Responsiveness to Activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Trans Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J Bone Mineral Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two Tissue-Resident Progenitor Lineages Drive Distinct Phenotypes of Heterotopic Ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci Trans Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/zeb.2016.1398","article-title":"A Zebrafish Model of Human Fibrodysplasia Ossificans Progressiva","volume":"14","author":"LaBonty","year":"2017","journal-title":"Zebrafish"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.24606","article-title":"Animal Models of Fibrodysplasia Ossificans Progressiva","volume":"247","author":"LaBonty","year":"2018","journal-title":"Dev Dynamics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e53761","DOI":"10.7554\/eLife.53761","article-title":"Fibrodysplasia Ossificans Progressiva Mutant ACVR1 Signals by Multiple Modalities in the Developing Zebrafish","volume":"9","author":"Allen","year":"2020","journal-title":"eLife"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1003888","DOI":"10.1371\/journal.pcbi.1003888","article-title":"Size Does Matter: An Integrative In Vivo-in Silico Approach for the Treatment of Critical Size Bone Defects","volume":"10","author":"Carlier","year":"2014","journal-title":"PloS Comput Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2014.10.012","article-title":"Oxygen as a Critical Determinant of Bone Fracture Healing-a Multiscale Model","volume":"365","author":"Carlier","year":"2015","journal-title":"J Theor Biol"},{"key":"B58","first-page":"1","article-title":"The Medical Management of Fibrodysplasia Ossificans Progressiva: Current Treatment Considerations","volume":"2","author":"Kaplan","year":"2021","journal-title":"Proc Intl Clin Council FOP"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e95042","DOI":"10.1172\/jci.insight.95042","article-title":"Saracatinib is an Efficacious Clinical Candidate for Fibrodysplasia Ossificans Progressiva","volume":"6","author":"Williams","year":"2021","journal-title":"JCI Insight"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28710","article-title":"BMP and mTOR Signaling in Heterotopic Ossification: Does Their Crosstalk Provide Therapeutic Opportunities","volume":"120","author":"Wu","year":"2019","journal-title":"J Cell Biochem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.10.007","article-title":"An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva","volume":"11","author":"Hino","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2334","article-title":"Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor-\u03b3 Agonists","volume":"17","author":"Shimono","year":"2011","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.010","article-title":"Retinoid Roles and Action in Skeletal Development and Growth Provide the Rationale for an Ongoing Heterotopic Ossification Prevention Trial","volume":"109","author":"Pacifici","year":"2018","journal-title":"Bone"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813495959","article-title":"Clinical Trials in Rare Disease: Challenges and Opportunities","volume":"28","author":"Augustine","year":"2013","journal-title":"J Child Neurol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13777","article-title":"Special Considerations for Clinical Trials in Fibrodysplasia Ossificans Progressiva (FOP)","volume":"85","author":"Hsiao","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2728","article-title":"The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J Bone Mineral Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.bone.2020.115274","article-title":"Self-Reported Baseline Phenotypes From the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry","volume":"134","author":"Pignolo","year":"2020","journal-title":"Bone"},{"key":"B68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-3-11","article-title":"Adaptive Design Methods in Clinical Trials - A Review","volume":"3","author":"Chow","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.09.016","article-title":"Cartilage-Derived Retinoic Acid-Sensitive Protein (CD-RAP): A Stage-Specific Biomarker of Heterotopic Endochondral Ossification (HEO) in Fibrodysplasia Ossificans Progressiva (FOP)","volume":"109","author":"Lindborg","year":"2018","journal-title":"Bone"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2016.10.001","article-title":"Trace Element and Cytokine Concentrations in Patients With Fibrodysplasia Ossificans Progressiva (FOP): A Case Control Study","volume":"39","author":"Hildebrand","year":"2017","journal-title":"J Trace Elements Med Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2465w","article-title":"The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva","volume":"8","author":"Al Kaissi","year":"2016","journal-title":"J Clin Med Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2019.03.009","article-title":"Evolution of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva: An [(18)F]NaF PET\/CT Study","volume":"124","author":"Botman","year":"2019","journal-title":"Bone"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.011","article-title":"Imaging Assessment of Fibrodysplasia Ossificans Progressiva: Qualitative, Quantitative and Questionable","volume":"109","author":"Al Mukaddam","year":"2018","journal-title":"Bone"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.012","article-title":"[18f]NaF PET\/CT Scan as an Early Marker of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva","volume":"109","author":"Eekhoff","year":"2018","journal-title":"Bone"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.732728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:01:27Z","timestamp":1636545687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.732728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":74,"alternative-id":["10.3389\/fendo.2021.732728"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.732728","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"article-number":"732728"}}